Meta-analysis exploring the effect of oncogenic driver mutations on outcome of metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI) or docetaxel (doc).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9029-9029
Author(s):  
Abena Agyeman ◽  
Jonathon Joseph Vallejo ◽  
Adrian Myers ◽  
Gideon Michael Blumenthal
Sign in / Sign up

Export Citation Format

Share Document